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Abstract
Purpose: The aims of this study were, firstly, to evaluate solid breast masses based on their malignancy potential and to 
determine whether the strain elastography ratio (SER) can contribute to classical grey-scale ultrasonography findings, 
and secondly, to define objective BIRADS US scores using ultrasound (US) and SER findings.
Material and methods: A total of 280 patients and 297 solid breast masses were evaluated using sonographic and elas-
tographic data. The SER was measured for each lesion. 
Results: The positive predictive values (PPV) for each criterion was calculated to be between 35% and 83.3%. The lowest 
PPV was obtained from hypoechogenicity (35%) and the highest PPV was obtained for anti-parallel features (83.3%). 
The difference between the mean SER of benign and malignant lesions was statistically significant. After ROC analysis, 
the SER cut-off value was calculated to be 3.1 for determining if the mass was benign or malignant. Mass scores were 
calculated for each solid breast mass based on positive predictive values, and BIRADS US score was defined as the sum 
of mass scores. 
Conclusions: SER findings can be used as malignancy criteria in evaluating solid breast masses. BIRADS US score can 
be objectively determined based on US and elastography features instead of doing subjective scoring. As an addi-
tional result, all solid breast masses have the possibility to be malignant, even though US and elastography findings 
indicate the opposite. 
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Introduction
Breast cancer is the most frequently diagnosed malignan-
cy and the leading cause of cancer death among women 
worldwide [1]. The majority of breast cancers originate 
from solid masses. Although mammography (MG) and 
magnetic resonance (MR) findings are being used, when 
a solid breast mass is encountered, biopsy indications are 
predominantly determined from ultrasound (US) find-
ings [2].
The reason for this is that US has an important poten-
tial in determining the malignancy likelihood for a lesion. 
A malignancy potential scoring system named BIRADS 
was described by the American College of Radiology. 
To use US findings only, a BIRADS US score was also 
defined. In this scoring method, the lesion’s malignancy 
potential is subjectively determined [3,4]. 
Newly introduced elastography methods may also 
contribute to this prediction by measuring the stiffness of 
the mass. There are two main methods of assessing stiff-
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ness (elasticity) of a mass: strain elastography and shear 
wave elastography. In strain elastography, the stiffness of 
the mass can be viewed from the degree of strain (dis-
placement) on manual compression. This technique is 
operator dependent and only gives a semi-quantitative 
estimation of tissue stiffness. With shear wave technology, 
the stiffness of a specific area is calculated by the device 
software without a comparison [5-7]. 
Currently, a significant proportion of breast biopsies 
are performed under US guidance in interventional ra-
diology. This is because the method is real-time, easy to 
apply, and does not use ionising radiation [8-12]. 
Our aim in this study was to determine whether SER 
findings can contribute to US findings in evaluating solid 
breast masses and to define an objective US score using 
US-elastography findings.
Material and methods
A total of 280 patients and 297 solid breast masses were 
evaluated by performing USG-guided biopsy in our insti-
tute between October 2014 and September 2016.
Initially, all patients were evaluated with US. Transverse 
diameter, vertical diameter, border appearance (if there 
was microlobulation and spiculation), evidence of micro- 
calcifications (MC), and acoustic transmission of solid 
breast masses were evaluated. 
If the lesion’s long axis parallel to skin/long axis per-
pendicular to skin ratio was greater than 1, then this lesion 
was considered as lying parallel to the skin. Conversely, if 
the ratio was less than 1, then this lesion was considered 
as lying anti-parallel to the skin. If the ratio was equal to 1, 
it was excluded from evaluation. Anti-parallel placement 
was noted as a malignancy feature.
Acoustic transmission of the lesions was evaluated from 
their posterior acoustic property. If there was a posterior 
acoustic shadow, then it was noted as a malignancy feature.
Elastography strain ratio was measured for each le-
sion. The ratio was calculated automatically by the US de-
vice after sampling two regions of interest (ROI). The first 
ROI was obtained from the lesion and the other from the 
adjacent breast tissue. The ROI area of each lesion was as 
large as possible.
This study was approved by our Institute Research 
Ethics Committee.
Core needle biopsy procedure
Before the procedure, all patients were questioned for 
contraindications, such as anticoagulant medications or 
over-anxiety preventing core needle biopsy (CNB).
After necessary sterilisation was provided, topical 
anaesthetics were used to reduce pain at the procedure 
site. 
The US devices were the Aplio 500 (Toshiba Medical 
Systems Europe) and the Hitachi Arietta V70 (Hitachi Med-
ical Systems Europa). The probe chosen was a 7.2-14 MHz 
linear probe. The probe was covered with a sterile instru-
ment. All CNB procedures were performed with 14- or 
16-gauge disposable and reusable needle systems. Range of 
fire was chosen as 15 and 22 mm according to the lesion 
and the patient conditions. 
All procedures were performed by the same interven-
tional radiologist with four years of experience.
After haemostasis was confirmed, evidence of bleed-
ing under the skin was controlled with US. All patients 
were observed for a short period of time.
Histopathological results were obtained. Benign and 
malignant results were calculated as frequency in per cent 
(Table 1).
After all data was collected from all resources, then 
positive predictive values were calculated for the features 
considered as indicative for malignancy. 
Mass scores were calculated based on positive predic-
tive values for each lesion. Mass score was determined as 
an approximate value of PPV for each sonography – elas-
tography feature (Table 2). 
Finally, estimated BIRADS US scores were calculated 
according to the total mass score. The malignancy ratios 
were found to be completely concordant with the litera-
ture (Table 3).
Statistical analysis
Student’s t-test was used to compare mean strain ratios for 
benign and malignant solid masses. 
ROC analysis was used to determine the cut-off strain 
ratio point.
IBM SPSS Statistics program version 22 was used for 
statistical analysis.
Table 1. Distribution of benign and malignant lesions
Histopathology Count %
Fibroadenoma 109 51.9
Ductal epithelial hyperplasia 17 8
Lipoma, lipogranuloma 16 7.5
Mastitis 13 6.1
Other: fibrocystic, benign adenomatoid changes 56 26.4
Total 211
Invasive ductal carcinoma 68 79
Invasive lobular carcinoma 6 7
Carcinoma from distant sites 2 2.3
Mucinous carcinoma 7 8.1
Neuroendocrine carcinoma 2 2.3
Sarcoma 1 1.2
Total 86
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Results
This study included 280 patients and 297 solid breast masses. 
There were 278 females as compared to 2 males in the study.
The average age was 45.6 years (range from 19 to 79). 
Eighty-six of 297 solid breast masses were malignant 
(29%) and the remaining 211 were benign. The most fre-
quently seen benign tumour was fibroadenoma. The num-
ber of proven fibroadenomas was 109 with a percentage of 
51.9. Other benign results could be determined as ductal 
epithelial hyperplasia, lipoma, granuloma, mastitis, etc. 
On the other hand, the most frequent malignant tumour 
was invasive ductal carcinoma, as expected. The total 
number was 68, corresponding to 79%. Subsequent ma-
lignant tumour types were invasive lobular carcinoma and 
mucinous carcinoma, with equal frequencies. Distribution 
of benign and malignant solid breast masses according to 
their frequencies is shown in Table I.
Positive predictive values (PPV) were calculated based 
on US and elastography features after considering malig-
nancy. The highest PPV was obtained from the anti-par-
allel placement feature at 83.3%, whereas the lowest value 
was from hypo-echo dominance at 35%. Table II shows 
the positive predictive values and mass scores of the sono-
graphic features obtained in our study.
Figure 1 and Figure 2 show solid breast masses with 
their mass score as benign and malignant examples.
The mean strain ratio for benign lesions was calcu-
lated as 2.1 ± 1.6 (mean ± standard deviation), whereas 
the mean strain ratio for malignant lesions was 4.6 ± 2.6. 
The difference between the mean strain ratio of benign and 
malignant lesions was statistically significant (p < 0.01). 
In ROC analysis, the cut-off value was calculated to be 3.1, 
and the positive predictive value of strain ratio for malig-
nant lesions was calculated to be 70.6 (Figure 3).
Discussion
The majority of breast core needle biopsies are performed 
under the guidance of US. Conventional radiologists tend 
to use MRI guidance when US findings are suspicious-neg-
ative. MRI is also an expensive modality and requires spe-
cial equipment. On the other hand, MG is uncomfortable 
for many patients and uses ionising radiation. MG guid-
ance can also be considered when microcalcifications 
accompany the suspicious mass or if they are the single 
positive sign. Finally, US is the single modality allowing 
real-time guidance, making it the preferred method. 
The CNB procedure was used to obtain samples for 
histopathological diagnosis. CNB is the preferred proce-
dure for solid breast masses, and the results are very con-
vincing [13]. Brenner et al. [14] stated that there was a 99% 
sensitivity ratio using 14-gauge needles and five samples 
for each lesion from their multicentre retrospective study. 
When our histopathological findings were evaluated, as 
the first result, half of all benign lesions were fibroadeno-
mas (52%), corresponding to the literature. The most fre-
quent malignant solid mass was invasive ductal carcinoma. 
Sixty-eight invasive ductal carcinomas were defined, which 
was 79% of all malignant diagnoses. This result was also 
Table 2. Positive predictive values (PPV) for malignant, ultrasonography (USG), and strain wave elastography criteria
USG – elastography criteria True positive Total positive PPV % Mass score
Anti-parallel placement to skin 65 78 83.3 0,8
Spiculation-microlobulation 97 122 79.5 0,8
Posterior acoustic shadow 61 88 69.3 0,7
Hypo echo dominance 91 256 35.5 0,35
Presence of microcalcifications 34 46 73.4 0,7
Strain-ratio over cut-off value 53 75 70.6 0,7
Table 3. Malignancy ratios via BIRADS score and comparison with the literature
Mass score total EBS Malignant Benign Malignity ratio (%) Literature
0-0.49 3 2 111 1.8 0-2
0.5-1.49 4a 4 38 9.5 2-10
1.5-2.49 4b 41 58 41.4 10-49
2.5-3.49 4c 31 4 88.6 50-95
3.5-4.2 5 8 0 100 95-100
Total 86 211
EBS – Estimated BIRADS score
 Defining objective BIRADS US score
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Figure 1. 35-year-old female. 7 × 4 mm sharp borders, parallel placement. No posterior acoustic change. Strain ratio: 0.4. Mass score: 0.35. EBS: 3. Diagnosis: 
Fibroadenoma
Figure 2. 60-year-old female. 14 × 18 mm irregular borders anti-parallel placement. No posterior acoustic change and microcalcification. Strain ratio: 4.53. 
Mass score: 0.35 + 0.8 + 0.8 + 0.7 = 2.65. EBS: 4c. Diagnosis: Invasive ductal carcinoma
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similar to the literature; around 80% of all breast cancers 
are invasive ductal carcinomas [15]. 
Our study included 278 females and two male patients. 
Breast carcinomas are found in women a hundred times 
more frequently than in men. Most of the time, male pa-
tients consulting an interventional radiology department 
complain about gynecomastia and solid breast masses 
are rarely seen. Only one male patient had invasive duct-
al carcinoma in our study. Invasive ductal carcinoma is 
the most frequently seen malignant tumour in males, as in 
females [16,17].
In order to define the BIRADS US score as a first step, 
the PPV was calculated for features indicative of malig-
nancy. The PPV of anti-parallel placement to the skin was 
83.3%, and the number of lesions having this feature was 
65. Parallel or anti-parallel placement to the skin surface 
by the long axis of the mass is an important feature in 
terms of benign-malignant differentiation. When the 
course of the mass is parallel to the skin, it favours benig-
nity, while, conversely, anti-parallel placement indicates 
spreading of the lesion throughout the tissue planes. Stud-
ies on the PPV of the anti-parallel position for malignancy 
showed values of 69-81.2% [18-20]. 
The spiculated border feature showed a PPV of 79.5%, 
and 97 of the lesions matched the criteria. Stavros et al. 
[18] and Constantini et al. [19] evaluated spiculation and 
microlobulation separately. Stavros et al. reported PPV 
values of 91.8% and 48.2% and Constantini et al. reported 
87.5% and 100%, respectively. Hong et al. [20] calculated 
the PPV for microlobulation and reported an 86% ratio. 
Radial protrusions characterised with spiculated margins 
extending from the mass have one of the highest PPV in 
terms of sonographic findings of malignancy. Border spicu-
lation of the mass results from tumour cells infiltrating into 
the surrounding tissue. Because of the similar density of 
the hypoechoic spiculation and its extending fibrous tissue 
surrounding the malignant mass, hypoechoic spiculation 
may be indistinguishable on mammograms. For these cases 
US is very helpful.
Evidence of a posterior acoustic shadow indicates 
poor acoustic transmission and is considered as a ma-
lignancy criterion. The PPV was found to be 69.3% for 
this criterion in our study, and 61 of the lesions had this 
feature. Presence of posterior acoustic shadow due to less 
attenuation of the sound beam indicates that the mass 
could be malignant. The PPV values vary between 64.9% 
and 78.9% in terms of a malignancy indicator [18,19]. 
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Figure 3. The ROC curve obtained from elastography strain ratio values
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Figure 4. A 5-mm solid breast mass in the upper inner quadrant with malignant appearance. Presence of micro-calcification can be seen. Diagnosis: Invasive 
ductal carcinoma
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Developing a desmoplastic reaction also causes shadow-
ing in the surrounding tissue rather than the malignant 
mass itself. Acoustic shadow is commonly seen in invasive 
ductal carcinoma, which grows slowly and allows a tubu-
lar desmoplastic reaction [21].
Hypo-echo dominance showed a PPV of 35.5%, and 
256 lesions had this criterion. The positive predictive 
value and the mass score were very low for this feature. 
The main reason for this is that fibroadenomas generally 
appear as hypoechoic and they constitute nearly half of 
the benign lesions.
The PPV for presence of MC was found to have a ra-
tio of 73.4%. Thirty-four of 46 solid masses with MC 
were malignant. MC is a strong indicator of malignancy. 
The main challenging issue for determining BIRADS score 
by using US alone is defining MC. The contribution of 
a MG examination cannot be ignored, especially for pa-
tients over age 40 years and with adipose-rich breast tis-
sue. On the other hand, with improvements of US imaging 
technology in recent years combined with careful exami-
nation and optimised imaging presets with sparing long 
time, even MCs can be detected more than expected (Fig-
ure 4). In our study, a careful and long examination was 
performed for each patient before the biopsy procedure. 
The difference between the mean strain ratio of benign 
and malignant lesions was statistically significant. This re-
sult proves that the strain ratio can be used as a malignancy 
indicator in evaluating solid breast masses. In ROC anal-
ysis, the curve obtained was not ideal because of variable 
strain ratio values (standard deviations). The cutoff value 
was calculated to be 3.1. Measuring strain ratios is a very 
user dependent issue, so we believe high standard devia-
tions can be explained in this way. Another potential reason 
is the strain ratio of adjacent breast tissue. In our experi-
ence, measuring the ratio by comparing to adipose or fi-
broglandular tissue does not affect the results substantially. 
There are some articles determining the contribution 
of elastography to conventional USG findings. Their re-
sults can be summarised as follows: Mean SER is higher 
for malignant masses and the difference is statistically sig-
nificant. Sonoelastography has a higher specificity than 
B-mode ultrasound in the differentiation between benign 
and malignant masses, and it has the potential to reduce 
biopsies with benign results. Comparing the diagnostic 
characteristics of the three methods with reference to the 
definitive histological results for malignant breast lesions, 
the best diagnostic accuracy is obtained when US, elastog-
raphy, and colour Doppler imaging are combined [22-24].
In summary, five major grey-scale indicators and SER 
can be used to determine BIRADS US score. They are: 
anti-parallel placement to the skin, spiculated and irregu-
lar borders, posterior acoustic shadowing (which indicates 
poor transmission), hypo-echo dominance, and presence 
of MC. 
If BIRADS US scores (EBS) were calculated according 
to mass score obtained from the PPV of USG malignancy 
criteria, malignancy ratios were completely concordant 
with the literature. Therefore, these features can be de-
fined as being competent for evaluation.
A report by Orel et al. [25] evaluated positive predic-
tive values and determined BIRADS scores. They followed 
the same idea as our research, but the article was con-
cerned with mammographic findings (mass, micro-cal-
cifications, mass with calcifications, asymmetric density, 
developing density, architectural distortion, architectural 
distortion with calcifications, and dilated duct).
Another surprising result obtained in the current 
work was that two of 86 malignant lesions had none of 
the malignancy indicators mentioned above, and their 
strain ratios were also below 3.1. Consequently, despite 
their benign appearance, every solid breast mass still has 
malignancy potential.
The main limitation of this study was our inability to 
use shear wave elastography, which is a newer and poten-
tially more objective method. The device we used did not 
have that option. 
Conclusions
SER can make a contribution to classic US findings, 
and BIRADS US scores can be objectively determined 
based on US and elastography features instead of using 
subjective scoring in evaluating solid breast masses. All 
solid breast masses still have the possibility to be malig-
nant, even though US and elastography findings indicate 
the opposite.
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